Robert LeBoyer

Stock Analyst at Noble Capital Markets

(0.26)
# 2528
Out of 5,329 analysts
20
Total ratings
31.25%
Success rate
2.32%
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
TNXP Tonix Pharmaceutical...
Reiterates: Outperform
70 70
18 288.89% 2 Mar 20, 2025
NTRB Nutriband
Initiates Coverage On: Outperform
13
6.3 106.35% 1 Jan 22, 2025
GOVX Geovax Labs
Maintains: Outperform
6 10
0.99 910.1% 2 Aug 19, 2024
UNCY Unicycive Therapeuti...
Initiates Coverage On: Outperform
6
0.65 823.08% 1 Feb 14, 2024
CVKD Cadrenal Therapeutic...
Initiates Coverage On: Outperform
60
16.21 270.14% 1 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
3.28 204.88% 1 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
2.5 460% 1 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
150
n/a n/a 1 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.48 1566.67% 2 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
0.65 18361.54% 1 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.33 28.62% 1 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
825000
n/a n/a 1 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
1.66 803.61% 2 Mar 8, 2018